The inhibition of CXCL8 with the CXCL8-neutralizing antibody reduced the ability of CXCL8 to promote VEGF secretion in bladder cancer cells, suggesting that CXCL8 in CM plays a role in this process (Figs. 5E–5G). This evidence concerns the gene CXCL8 and urinary bladder carcinoma.